Cycloastragenol treatment in a diabetic kidney disease murine model mitigated mitochondrial oxidative overload and renal tubular injury through stimulation in the transcriptional factor EB (TFEB) nuclear translocation [40]. This evidence concerns the gene TFEB and diabetic kidney disease.